ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 698 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
 


 

 
     
    Advanced search
 

 
 
     
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  


    Abstract
    Introduction
    Materials and Me...
    Results
    Discussion
    References
    Article Figures
    Article Tables

 Article Access Statistics
    Viewed15720    
    Printed479    
    Emailed33    
    PDF Downloaded2310    
    Comments [Add]    
    Cited by others 28    

Recommend this journal

 


 
ORIGINAL ARTICLE Table of Contents   
Year : 2010  |  Volume : 13  |  Issue : 1  |  Page : 16-21
Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG


Department of Anesthesiology, Yeditepe University, Kozyatagi, Istanbul, Turkiye, Turkey

Click here for correspondence address and email

Date of Submission23-Feb-2009
Date of Acceptance13-Aug-2009
Date of Web Publication11-Jan-2010
 

   Abstract 

During induction of general anesthesia hypertension and tachycardia caused by tracheal intubation may lead to cardiac ischemia and arrhythmias. In this prospective, randomized study, dexmedetomidine has been used to attenuate the hemodynamic response to endotracheal intubation with low dose fentanyl and etomidate in patients undergoing myocardial revascularization receiving beta blocker treatment. Thirty patients undergoing myocardial revascularization received in a double blind manner, either a saline placebo or a dexmedetomidine infusion (1 µg/kg) before the anesthesia induction. Heart rate (HR) and blood pressure (BP) were monitored at baseline, after placebo or dexmedetomidine infusion, after induction of general anesthesia, one, three and five minutes after endotracheal intubation. In the dexmedetomidine (DEX) group systolic (SAP), diastolic (DAP) and mean arterial pressures (MAP) were lower at all times in comparison to baseline values; in the placebo (PLA) group SAP, DAP and MAP decreased after the induction of general anesthesia and five minutes after the intubation compared to baseline values. This decrease was not significantly different between the groups. After the induction of general anesthesia, the drop in HR was higher in DEX group compared to PLA group. One minute after endotracheal intubation, HR significantly increased in PLA group while, it decreased in the DEX group. The incidence of tachycardia, hypotension and bradycardia was not different between the groups. The incidence of hypertension requiring treatment was significantly greater in the PLA group. It is concluded that dexmedetomidine can safely be used to attenuate the hemodynamic response to endotracheal intubation in patients undergoing myocardial revascularization receiving beta blockers.

Keywords: Cardiac anesthesia, dexmedetomidine, fast track

How to cite this article:
Menda F, Koner O, Sayin M, Ture H, Imer P, Aykac B. Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG. Ann Card Anaesth 2010;13:16-21

How to cite this URL:
Menda F, Koner O, Sayin M, Ture H, Imer P, Aykac B. Dexmedetomidine as an adjunct to anesthetic induction to attenuate hemodynamic response to endotracheal intubation in patients undergoing fast-track CABG. Ann Card Anaesth [serial online] 2010 [cited 2018 Dec 11];13:16-21. Available from: http://www.annals.in/text.asp?2010/13/1/16/58829



   Introduction Top


Hypertension, arrhythmias and myocardial ischemia induced by endotracheal intubation are the results of a reflex increase in sympathetic and sympathoadrenal activity. [1] Opioids, local anesthetics, adrenergic blocking agents and vasodilating agents have been used to attenuate this. [1],[2],[3],[4],[5],[6],[7],[8],[9] High-dose opioid is preferred to attenuate this response in cardiac surgery patients. [10] However, fast- track anesthesia with low-dose fentanyl has gained popularity in recent years. [11],[12] This technique limits the use of excessive fentanyl doses during anesthesia induction and to block the hemodynamic effects of intubation, an adjunct may often be necessary.

α-2 adrenergic agonists decrease sympathetic tone [13],[14] and pre-operative use of clonidine, an α-2 adrenergic agonist has been shown to blunt the hemodynamic responses to noxious stimulation and to prevent the overall hemodynamic variability. [15],[16] It also reduces the need for anesthetics [15],[17],[18] and, therefore, can be used as an adjunct to general anesthetics. Dexmedetomidine, a more specific and selective α-2 adrenergic agonist than clonidine has a shorter duration of action than clonidine [19],[20] and because of its sedative and analgesic properties it also can be used as an adjunct to general anesthetics. [10],[21]

There is a study relating to the effects of dexmedetomidine on hemodynamic response to endotracheal intubation in patients undergoing coronary artery bypass graft (CABG), however, in this study dexmedetomidine has been used with high dose fentanyl (30 µg/kg). [10] which may interfere with the fast track protocol routinely used in our center.

This prospective, randomized, double blinded study was planned to investigate the hemodynamic effects of intravenous dexmedetomidine used as anesthetic adjunct during induction of anesthesia. We hypothesized that, in combination with fentanyl 5 µg/kg, intravenous dexmedetomidine infusion administered prior to endotracheal intubation may attenuate the hemodynamic response to intubation without causing hemodynamic compromise.


   Materials and Methods Top


After obtaining Ethics Committee approval, 30 patients undergoing CABG were enrolled in this study. The exclusion criteria were - ejection fraction less than 40%, age more than 60 years and body mass index (BMI) more than 30 kg/m 2 , left main coronary artery occlusion more than 50%, valvular dysfunction, preoperative medication with clonidine or alphametyl-dopa, history suggestive of sensitivity to drugs used during the study, preoperative left bundle branch block, and severe systemic disorders (e.g. insulin-dependent diabetes mellitus, kidney or liver insufficiency, severe respiratory disorder). Intubation attempt lasting longer than 20 seconds was also considered as exclusion criteria. All patients were receiving oral metoprolol (50 mg/day, if less than or equal to 70 kg, 100 mg/day, if more than 70 kg) before the surgery for at least one week. All patients received their cardiac medications two hours before surgery.

The study was designed in a placebo controlled, double blinded, randomized, prospective fashion. The patients were randomly seperated into two groups: placebo (PLA, n 1 =15) and dexmedetomidine (DEX, n 2 =15) by closed envelope method. Pre-medication consisted of midazolam 0.07 mg/kg given intra-muscularly 30 minutes before the surgery. Before arriving, at the operating room, a 16- gauge peripheral venous cannula was inserted into the right antecubital vein and according to study protocol all patients were prehydrated with 500 ml Lactated Ringer's solution. In the operation room, monitoring of 12 leadelectrocardiogram (ECG) , invasive blood pressure obtained via the right radial artery catheter, urinary output, pulse oxymetry, neuromuscular block level via train of four (TOF) Watch (Organon TOF-Watch® SX, Ireland) was initiated. All cannulations were performed under local anesthesia. In all patients, baseline systolic arterial pressure (SAPt 0 ), diastolic arterial pressure (DAP t 0 ), mean arterial pressure (MAP t 0 ) and baseline heart rate values (HR t 0 ) were recorded after a three minute resting period following the insertion of the radial artery catheter. The drug infusion (dexmedetomidine or saline placebo similar in appearance) was then commenced in a double blinded fashion. DEX group received a total dose of 1 µg/kg dexmedetomidine diluted in 100 ml sodium chloride (NaCl) solution in 15 minutes and the patients in PLA group received 100 ml NaCl solution in 15 minutes. After a stabilization period of 5 minutes, SAP t 1 , DAP t 1 , MAP t 1 and heart rate (HR t 1 ) were recorded. All the hemodynamic measurements were made by yet another anesthesiologist who was blinded to the groups.

A mixture of etomidate (0.3 mg/kg) and fentanyl (5 µg/ kg) was prepared for the induction of anesthesia. This mixture was infused via an infusion pump in three minutes immediately after t 1 hemodynamic recordings. After the loss of eyelid reflex, rocuronium 1 mg/ kg was administered intravenously to facilitate endotracheal intubation. Two minutes after administering the induction agents SAP t 2 , DAP t 2 , MAP t 2 and HR t 2 recordings were done and the trachea was intubated. Each intubation was performed by an anesthesiologist and accomplished within 20 seconds. Hemodynamic measurements were repeated after completion of administration of dexmedetomidine or placebo infusion and 1(t 3 ), 3 (t 4 ) and 5 (t 5 ) minutes after the endotracheal intubation. [Table 1] shows the definition criteria and stepwise treatment of hypotension, hypertension, bradycardia and tachycardia.

After the last recordings propofol 6-12 mg/kg/h and remifentanil 0.05-0.25 mcg/kg/min infusions were administered for maintenance of general anesthesia, troughout. Three minutes after the beginning of total intravenous anesthesia a 7-F central venous catheter was inserted into the right internal jugular vein. Nasogastric tubing, nasopharyngeal temperature monitoring and urinary catheterization were performed. Ringer's Lactate solution was infused at an approximate rate of 5 ml/kg/h. The total amount of intravenous fluids given administered was limited to 1000 ml prior to institution of cardiopulmonary bypass (CPB). Controlled mechanical ventilation was adjusted to maintain end-tidal carbon dioxide between 35-45 mmHg. During hypothermic (32 o C) CPB, propofol (2-3 mg/kg/h) and remifentanil (0.05-0.10 µg/kg/min) infusion was continued. At the end of the surgery patients were transferred to the surgical intensive care unit with propofol and remifentanil infusion running.

All data are presented as mean ± SD (standard deviation). Demographic data were analyzed by Student's t test. Analysis of variance for repeated measures (ANOVA) was used to analyze changes over time. When statistical significance was found, the difference between two different data for each variable was analyzed by Mann Whitney-U test. Inter-group comparisons for hemodynamic parameters were made with Mann Whitney-U test. To compare the incidence of hypertension, hypotension, bradycardia and tachycardia between the groups, Fisher's exact test was used, P < 0.05 considered significant. Power analysis was carried out by statistical software Package G Power 3.0® and while a= 0.10, 1-â=0.80, d= 0.8 and allocation ratio n 1 /n 2 =1 the effective sample size was 30 for comparison of independent means.


   Results Top


The groups were similar with respect to age, weight, gender [Table 2]. Post-operative mechanical ventilation time and intensive care unit stay were identical among the groups. Postoperative mechanical ventilation time was 240.7 ± 37.9 min in PLA group and 244.7 ± 41.5 min in DEX group ( P > 0.05). Intensive care unit (ICU) stay was 1.3 ± 0.5 days in PLA group and 1.3 ± 0.4 days in DEX group ( P > 0.05).

[Figure 1],[Figure 2],[Figure 3],[Figure 4] show HR, MAP, SAP and DAP values of the two groups during the study. In the DEX group (HR) was significantly lower than the baseline in all measurement times. In the placebo group all the HR values, except for t 2 , were higher than the baseline value. In the placebo group, HR increased significantly after the intubation compared to baseline (P = 0.03, mean difference of 6.8, CI 95% (0.6-13)) (but not compared to the baseline), whereas it decreased in the DEX group at the same time interval (P = 0.004, mean difference of 10.0, CI 95% 3.8-16.3). Inter-group comparisons are shown in [Figure 1],[Figure 2],[Figure 3],[Figure 4].

In DEX group, MAP was significantly lower compared to baseline values at all the measurement times, whereas in the placebo group only MAP t 2 and t 5 were significantly lower than the baseline value. The decrease of MAP from baseline to t 2 and to t 5 was not different between the groups.

In DEX group SAP was significantly lower throughout the study in comparison to the baseline values, whereas in the PLA group SAP significantly decreased compared to baseline only after induction of anesthesia and 5 minutes after intubation. From baseline to t 2 and to t 5 the SAP decrease was similar in both groups (P > 0.05). In the PLA group SAP increased significantly after the intubation compared to post-induction period (P = 0.008, mean difference of 24.6, CI 95% (7.4-41.9), whereas it did not change significantly in DEX group after the intubation.

In DEX group DAP was significantly lower compared to baseline values at all the measurement times, while in the PLA group only DAP t2 and DAP t5 were significantly lower than the baseline value. The decrease of DAP t2 and DAP t5 from the baseline values (ÄDAP t 0 -t 2 and ÄDAP t 0 -t 5 ) was not different between the two groups. There was a significant increase in DAP in the placebo group after endotracheal intubation (P=0.03, mean difference of 17, CI 95% (7- 26.9); whereas it did not change after the intubation in the DEX group.

The incidence of hypertension, hypotension, bradycardia and tachycardia in two groups are shown in [Table 3]. The incidence of tachycardia, hypotension and bradycardia was not different among the two groups. The incidence of hypertension was significantly higher in PLA group (P=0.036). In all patients hypotension was treated with 500 mL crystalloid fluid replacement and none of them required ephedrine boluses during the induction period. Fluctuation of the invasive arterial blood pressure waveform guided the fluid therapy.


   Discussion Top


The decrease in the BP and stabilization in the placebo group after induction may be related to preoperative beta blocker therapy. The heart rate, however, increased following intubation in both groups, but there was no difference in the number of patients having tachycardia in the two groups (two vs five patients). In the study group, there was a significant decrease in HR and BP at all stages. However, this change was acceptable and desirable as no bradycardia was observed in any of the patients and hypotension occurred in three patients.

Myocardial ischemia might occur during the induction - intubation sequence in patients with coronary artery disease. Intraoperative ischemia has been associated with a high rate of perioperative myocardial infarction. [4]

Opioids, adrenergic blocking agents, vasodilating agents and local anesthetics have been used to attenuate the hemodynamic effects of endotracheal intubation. In a study, Lidocaine and nitroglycerin were found to be ineffective in controlling the hemodynamic response to laryngoscopy and intubation. [22]

Dexmedetomidine has analgesic and sedative effects [10],[21] in addition to blunting the hemodynamic response to endotracheal intubation as shown in our study. On the other hand, dexmedetomidine has also been shown to reduce the extent of myocardial ischemia during cardiac surgery. [21] The above-mentioned properties of dexmedetomidine may encourage anesthesiologists to use it in addition to low dose fentanyl and etomidate anesthetic induction to attenuate the hemodynamic response.

Jalonen et al, [10] used dexmedetomidine as an anesthetic adjunct in CABG patients. They used the high dose pure opioid tecnique (30 µg/kg iv fentanyl) during cardiac anesthesia induction. Since high dose opioid use during fast track cardiac anesthesia is abandoned. [11],[12] , this study was planned with low dose fentanyl.

Dexmedetomidine can lead to bradycardia and hypotension. [23],[24],[25],[26],[27],[28] Erkola et al, have shown in their study that in patients undergoing abdominal hysterectomy pre-medicated with dexmedetomidine, bradycardia was more common than in those who were premedicated with midazolam. Alone [29] theoretically, excessive hypotension and bradycardia induced by dexmedetomidine could limit its use in patients with ischemic heart disease in patients receiving beta blocker therapymay be contra indicated. But, in our study, the incidence of hypotension was not any higher than that observed in placebo group patients, and none of the patients experienced bradycardia requiring treatment. Jalonen et al, [10] used dexmedetomidine as an anesthetic adjunct in CABG patients receiving beta blockade and reported that the intraoperative incidence of bradycardia requiring treatment was not more common in the dexmedetomidine group than in the placebo group. The authors suggested that, with the beta-receptors already blocked, additional sympathetic blockade with dexmedetomidine did not appear to decrease the heart rate further. The suggestion by Jalonen and coworkers appear relevant to our study as well.

This study investigated the hemodynamic effects of dexmedetomidine during induction and intubation period, further studies investigating the myocardial protecting properties of dexmedetomidine during this stage of anesthesia may be needed to provide information about that aspect of the drug.

We conclude that dexmedetomidine effectively blunts the hemodynamic response to endotracheal intubation in patients undergoing myocardial re-vascularization and can be safely used at induction of general anesthesiain combination with fentanyl, even among patients receiving beta blockers.

 
   References Top

1.Mikawa K, Nishina K, Maekawa N, Obara H. Comparison of nicardipine, diltiazem and verapamil for controlling the cardiovascular responses to tracheal intubation. Br J Anaesth 1996;76:221-6.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]  
2.Fassoulaki A, Kaniaris P. Intranasal administration of nitroglycerine attenuates the pressor response to laryngoscopy and intubation of the trachea. Br J Anaesth 1983;5:49-52.  Back to cited text no. 2      
3.Stoelting RK. Attenuation of blood pressure response to laryngoscopy and tracheal intubation with sodium nitroprusside. Anesth Analg 1979;58:116-9.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]  
4.Mikawa K, Obara H, Kusunoki M. The effect of nicardipine on the cardiovascular response to tracheal intubation. Br J Anaesth 1990;64:240-2.  Back to cited text no. 4  [PUBMED]  [FULLTEXT]  
5.Charuluxananan S, Kyokong O, Somboonviboon W, Balmongkon B, Chaisomboonpan S. Nicardipine versus lidocaine for attenuating the cardiovascular response to endotracheal intubation. J Anesth 2000;14:77-81.  Back to cited text no. 5  [PUBMED]  [FULLTEXT]  
6.Martin DE, Rosenberg H, Aukburg SJ. Low dose fentanyl blunts circulatory responses to tracheal intubation. Anesth Analg 1982;6:680-4.  Back to cited text no. 6      
7.KO SH, Kim DC, Han YJ, Song HS. Small dose fentanyl: optimal dose of injection for blunting the circulatory responses to tracheal intubation. Anesth Analg 1998;86:658-61.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]  
8.Cork RC, Weiss JL, Hameroff SR, Bentley J. Fentanyl preloading for rapid sequence induction of anesthesia. Anesth Analg 1984;63; 63:60-4.  Back to cited text no. 8      
9.Lev R, Rosen P. Prophylactic lidocaine use preintubation: a review. J Emerg Med 1994;12:499-506.  Back to cited text no. 9  [PUBMED]  [FULLTEXT]  
10.Jalonen J, Hynynen M, Kuitunen A. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997;86:331-45.  Back to cited text no. 10      
11.Cheng DC. Fast-track cardiac surgery: economic implications in postoperative care. J Cardiothorac Vasc Anesth 1998;12:72-9.   Back to cited text no. 11  [PUBMED]  [FULLTEXT]  
12.Engoren M, Luther G, Fenn-Buderer N. A comparison of fentanyl, sufentanil, and remifentanil for fast-track cardiac anesthesia. Anesth Analg 2001;93:859-64.  Back to cited text no. 12  [PUBMED]  [FULLTEXT]  
13.Maze M, Tranquilly W. a-2 adrenoceptor agonists: Defining the role in clinical anesthesia. Anesthesiology 1991;74:581-605.  Back to cited text no. 13      
14.Aantaa R, Scheinin M. a-2-adrenergic agents in anesthesiology. Acta Anaesthesiol Scand 1993;37:433-48.  Back to cited text no. 14  [PUBMED]  [FULLTEXT]  
15.Flacke JW, Bloor BC, Flacke WE, Wong D, Daza S, Stead SW. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 1987;67:909-17.  Back to cited text no. 15      
16.Quintin L, Bonnet F, Macquin I. Aortic surgery: Effect of clonidine on intraoperative catecholaminergic and circulatory stability. Acta Anaesthesiol Scand 1990;34:132-7.  Back to cited text no. 16      
17.Kaukinen S, Pyykko. Potentiation of halothane anaesthesia by clonidine. Acta Anaesthesiol Scand 1979;23:107-11.  Back to cited text no. 17      
18.Bloor BC, Flacke WE. Reduction of halothane anesthetic requirements by clonidine, an a-2 -adrenergic agonist. Anest Analg 1982;61:741-5.  Back to cited text no. 18      
19.Virtanen R, Savola J, Nyman L. Characterization of the selectivity, specifity and potency of medetomidine as an a-2 adrenoceptor agonist. Eur J Pharmacol 1988;9-14.  Back to cited text no. 19      
20.Scheinin H, Virtanen R, MacDonald E, Lammintausta R. Medetomidine-a novel a-2-adrenoceptor agonist:A review of its pharmacological effects. Prog Neuro-Psychopharmacol Biol Psychiatry 1989;13:635-51.  Back to cited text no. 20      
21.Wijeysundera DN, Naik JS, Beattie WS. a-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta analysis. Am J Med 2003;114:742-52.  Back to cited text no. 21  [PUBMED]  [FULLTEXT]  
22.Singh H, Vichitvejpaisal P, Gaines GY, White PF. Comparative effects of lidocaine, esmolol and nitroglycerin in modifying the hemodynamic response to laryngoscopy and intubation. J Clin Anesth 1995;7:5-8.  Back to cited text no. 22  [PUBMED]  [FULLTEXT]  
23.Martin E, Ramsay G, Mantz J, Sum-Ping ST. The role of the a-2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 2003;18:29-41.  Back to cited text no. 23  [PUBMED]  [FULLTEXT]  
24.Ben-Abraham R, Ogorek D, Weinbroum AA. Dexmedetomidine: a promising agent for anesthesia and perioperative care. Isr Med Assoc J 2000;2:793-6.  Back to cited text no. 24  [PUBMED]  [FULLTEXT]  
25.Khan ZP, Ferguson CN, Jones RM. a-2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia 1999;54:146-65.  Back to cited text no. 25  [PUBMED]  [FULLTEXT]  
26.Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia 1997;52:736-44.  Back to cited text no. 26  [PUBMED]  [FULLTEXT]  
27.Scheinin H, Jaakola ML, Sjovall S, Ali-Melkkila T, Kaukinen S, Turunen J, et al. Intramuscular dexmedetomidine as premedication for general anesthesia: A comparative multicenter study. Anesthesiology 1993;78:1065-75.  Back to cited text no. 27      
28.Yildiz M, Tavlan A, Tuncer S, Reisli R, Yosunkaya A, Otelcioglu S. Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation: perioperative haemodynamics and anaesthetic requirements. Drugs R D 2006;7:43-52.  Back to cited text no. 28  [PUBMED]  [FULLTEXT]  
29.Erkola O, Korttila K, Aho M, Haasio J, Aantaa R. Comparison of intramuscular dexmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesth Analg 1994;79:646-53.  Back to cited text no. 29      

Top
Correspondence Address:
Ozge Koner
Yeditepe Universitesi Hastanesi, Devlet yolu Ankara cad. 102/104, 34752 Kozyatagi,' Istanbul, Turkiye
Turkey
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.58829

Rights and Permissions


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 4]
 
 
    Tables

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 The Effect of Pre-Emptive Dexmedetomidine on the Incidence of Post-Thoracotomy Pain Syndrome in Patients Undergoing Coronary Artery Bypass Grafting
Morteza Jabbary Moghaddam,Ali Barkhori,Alireza Mirkheshti,Morteza Hashemian,Seyed Amir Mohajerani
Anesthesiology and Pain Medicine. 2016; Inpress(Inpress)
[Pubmed] | [DOI]
2 Dexmedetomidine Combined with General Anesthesia Provides Similar Intraoperative Stress Response Reduction When Compared with a Combined General and Epidural Anesthetic Technique
Yun Li,Bin Wang,Li-li Zhang,Shu-fang He,Xian-wen Hu,Gordon T. C. Wong,Ye Zhang
Anesthesia & Analgesia. 2016; 122(4): 1202
[Pubmed] | [DOI]
3 Dexmedetomidine Attenuates Myocardial Injury in Off-Pump Coronary Artery Bypass Graft Surgery
Xiaohui Chi,Mingfeng Liao,Xin Chen,Yilin Zhao,Liu Yang,Ailin Luo,Hui Yang
Journal of Cardiothoracic and Vascular Anesthesia. 2016; 30(1): 44
[Pubmed] | [DOI]
4 Clinical study to evaluate the role of preoperative dexmedetomidine in attenuation of hemodynamic response to direct laryngoscopy and tracheal intubation
Kamlesh Kumari,Satinder Gombar,Dheeraj Kapoor,Harpreet Singh Sandhu
Acta Anaesthesiologica Taiwanica. 2015; 53(4): 123
[Pubmed] | [DOI]
5 Evaluation of the Advantageous Anesthetic Properties of Dexmedetomidine Used as Hypotensive Agent Compared With Nitroglycerin in Orthognathic Surgery
Duangdee Rummasak,Benjamas Apipan
Journal of Oral and Maxillofacial Surgery. 2014; 72(12): 2428
[Pubmed] | [DOI]
6 Does premedication with dexmedetomidine provide perioperative hemodynamic stability in hypertensive patients?
Gulbin Sezen,Yavuz Demiraran,Ilknur Seker,Ibrahim Karagoz,Abdulkadir Iskender,Handan Ankarali,Ozlem Ersoy,Onur Ozlu
BMC Anesthesiology. 2014; 14(1): 113
[Pubmed] | [DOI]
7 Low-Dose Intramuscular Dexmedetomidine as Premedication: A Randomized Controlled Trial
Xiangcai Ruan
Medical Science Monitor. 2014; 20: 2714
[Pubmed] | [DOI]
8 A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants
Young-Eun Jang,Yong-Chul Kim,Hyun-Kyu Yoon,Young-Tae Jeon,Jung-Won Hwang,Eugene Kim,Hee-Pyoung Park
Journal of Anesthesia. 2014;
[Pubmed] | [DOI]
9 Dexmedetomidine: a review of applications for cardiac surgery during perioperative period
Xiaoyu Zhang,Xuan Zhao,Yingwei Wang
Journal of Anesthesia. 2014;
[Pubmed] | [DOI]
10 The sedative effects and the attenuation of cardiovascular and arousal responses during anesthesia induction and intubation in pediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine
Shan-Shan Wang,Ma-Zhong Zhang,Ying Sun,Chi Wu,Wen-Yin Xu,Jie Bai,Mei-Hua Cai,Lin Lin,Jerrold Lerman
Pediatric Anesthesia. 2013; : n/a
[Pubmed] | [DOI]
11 Dexmedetomidine as a sedative agent in critically Ill patients: A meta-analysis of randomized controlled trials
Pasin, L., Greco, T., Feltracco, P., (...), Finco, G., Zangrillo, A.
Source of the Document PLoS ONE. 2013;
[Pubmed]
12 result 3 Document Dexmedetomidine combined with narcotic anesthesia induction in coronary artery bypass graft surgery
Gümüş, F., Şinikoǧlu, S.N., Yektaş, A., (...), Erkalp, K., Alagöl, A.
Turkish Journal of Thoracic and Cardiovascular Surgery. 2013;
[Pubmed]
13 The Effect of Prophylactic Dexmedetomidine on Hemodynamic Disturbances to Double-Lumen Endotracheal Intubation: A Prospective, Randomized, Double-Blind, and Placebo-Controlled Trial
Tanyong Pipanmekaporn,Yodying Punjasawadwong,Somrat Charuluxananan,Worawut Lapisatepun,Pavena Bunburaphong
Anesthesiology Research and Practice. 2013; 2013: 1
[Pubmed] | [DOI]
14 A comparison of dexmedetomidine and propofol in patients undergoing electrophysiology study
Prachanpanich, N. and Apinyachon, W. and Ittichaikulthol, W. and Moontripakdi, O. and Jitaree, A.
Journal of the Medical Association of Thailand. 2013; 96(3): 307-311
[Pubmed]
15 The impact of dexmedetomidine infusion in sparing morphine consumption in off-pump coronary artery bypass grafting
Khalil, M.A. and Abdel Azeem, M.S.
Seminars in Cardiothoracic and Vascular Anesthesia. 2013; 17(1): 66-71
[Pubmed]
16 The effects of dexmedetomidine on hemodynamic responses to tracheal intubation in hypertensive patients: A comparison with esmolol and sufentanyl
Uysal, H.Y., Tezer, E., Türkoǧlu, M., Aslanargun, P., Başar, H.
Journal of Research in Medical Sciences. 2012; 17(1): 22-31
[Pubmed]
17 The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting
Sulaiman, S., Karthekeyan, R.B., Vakamudi, M., Sundar, A.S., Ravullapalli, H., Gandham, R.
Annals of Cardiac Anaesthesia. 2012; 15(1): 39-43
[Pubmed]
18 Perioperative administration of dexmedetomdine in intracranial aneurysm patients with hypertension
Qian, Z. and Zhao, J. and Deng, J. and Wang, L.
Medical Journal of Wuhan University. 2012; 33(5): 714-716
[Pubmed]
19 Myocardial ischaemia during coronary artery bypass graft surgery: a review of intervention strategies (Part 2)
P Motshabi
Southern African Journal of Anaesthesia and Analgesia. 2012; 18(3): 134
[Pubmed] | [DOI]
20 Myocardial ischaemia during coronary artery bypass graft surgery: a review of the pathophysiology (Part 1)
P Motshabi
Southern African Journal of Anaesthesia and Analgesia. 2012; 18(2): 70
[Pubmed] | [DOI]
21 Comparison of dexmedetomidine and remifentanil for attenuation of hemodynamic responses to laryngoscopy and tracheal intubation
Jeong Han Lee,Hyojoong Kim,Hyun-Tae Kim,Myoung-Hun Kim,Kwangrae Cho,Se Hun Lim,Kun Moo Lee,Young-Jae Kim,Chee-Mahn Shin
Korean Journal of Anesthesiology. 2012; 63(2): 124
[Pubmed] | [DOI]
22 Effect of dexmedetomodine assisted with brachial plexus block on stress in acute trauma patients
Miao, W.-L. and Zhang, Y.-X. and Hou, S.-J.
Chinese Critical Care Medicine. 2012; 24(11): 683-684
[Pubmed]
23 Comparison of dexmedetomidine and remifentanil for attenuation of hemodynamic responses to laryngoscopy and tracheal intubation
Lee, J.H. and Kim, H. and Kim, H.-T. and Kim, M.-H. and Cho, K. and Lim, S.H. and Lee, K.M. and Kim, Y.-J. and Shin, C.-M.
Korean Journal of Anesthesiology. 2012; 63(2): 124-129
[Pubmed]
24 Myocardial ischaemia during coronary artery bypass graft surgery: A review of intervention strategies (part 2)
Motshabi, P.
Southern African Journal of Anaesthesia and Analgesia. 2012; 18(3): 134-138
[Pubmed]
25 Attenuation of pressor response and dose sparing of opioids and anaesthetics with pre-operative dexmedetomidine
Bajwa, S.J.S. and Kaur, J. and Singh, A. and Parmar, S.S. and Singh, G. and Kulshrestha, A. and Gupta, S. and Sharma, V. and Panda, A.
Indian Journal of Anaesthesia. 2012; 56(2): 123-128
[Pubmed]
26 Hemodynamics in coronary artery bypass surgery
H. Karakaya Kabukçu,N. Sahin,Y. Temel,T. Aydogdu Titiz
Der Anaesthesist. 2011; 60(5): 427
[Pubmed] | [DOI]
27 Hemodynamics in coronary artery bypass surgery: Effects of intraoperative dexmedetomidine administration
Karakaya Kabukçu, H., Sahin, N., Temel, Y., Aydogdu Titiz, T.
Anaesthesist. 2011; 60(5): 427-431
[Pubmed]
28 High-dose Dexmedetomidine increases the opioid-free interval and decreases opioid requirement after tonsillectomy in children
Pestieau, S.R., Quezado, Z.M.N., Johnson, Y.J., Anderson, J.L., Cheng, Y.I., McCarter, R.J., Choi, S., Finkel, J.C.
Canadian Journal of Anesthesia. 2011; 58(6): 540-550
[Pubmed]



 

Top